|
|
||||||||
-glucosidase activation is
Ca2+ regulated
Department of Pharmacology, University of Lund, S-223 62 Lund, Sweden
An important signal involved in
glucose-stimulated insulin secretion is transduced through the action
of a lysosomal acid, glucan 1,4-
-glucosidase. We investigated the
Ca2+ dependency of this enzyme
activity in relation to insulin release. In isolated islets, increased
levels of extracellular Ca2+
induced a large increase in acid glucan 1,4-
-glucosidase activity accompanied by a similar increase in insulin release at both
substimulatory and stimulatory concentrations of glucose. At low
glucose the Ca2+ "inflow"
blocker nifedipine unexpectedly stimulated enzyme activity without
affecting insulin release. However, nifedipine suppressed 45Ca2+
outflow from perifused islets at low glucose and at
Ca2+ deficiency when intracellular
Ca2+ was mobilized by carbachol.
This nifedepine-induced retention of
Ca2+ was reflected in increased
acid glucan 1,4-
-glucosidase activity. Adding different
physiological Ca2+ concentrations
or nifedipine to islet homogenates did not increase enzyme activity.
Neither selective glucan 1,4-
-glucosidase inhibition nor the ensuing
suppression of glucose-induced insulin release was overcome by a
maximal Ca2+ concentration. Hence,
Ca2+-induced changes in acid
glucan 1,4-
-glucosidase activity were intimately coupled to similar
changes in Ca2+-glucose-induced
insulin release. Ca2+ did not
affect the enzyme itself but presumably activated either glucan
1,4-
-glucosidase-containing organelles or closely interconnected messengers.
pancreatic islets; lysosomal enzymes; nifedipine; emiglitate; carbachol; calcium ion
This article has been cited by other articles:
![]() |
R. Henningsson, A. Salehi, and I. Lundquist Role of nitric oxide synthase isoforms in glucose-stimulated insulin release Am J Physiol Cell Physiol, July 1, 2002; 283(1): C296 - C304. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Salehi, B.-G. Fan, M. Ekelund, G. Nordin, and I. Lundquist TPN-evoked dysfunction of islet lysosomal activity mediates impairment of glucose-stimulated insulin release Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E171 - E179. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |